1) antihypertensive peptides
抗高血压肽
1.
The isolation and purification, relations between structure and function, as well as the ACE inhibitory activities, the hypotensive mechanism and the in vivo absorption properties of milk and milk products-derived antihypertensive peptides were reviewed in the present paper, and the large market perspects also presented.
展望了乳源抗高血压肽的应用前景。
2) antihypertensive peptides
抗高血压活性肽
1.
In this paper,antihypertensive mechanism and structure activity relationship of antihypertensive peptides derived from milk protein were mainly summarized.
乳源抗高血压活性肽以其安全性、无副作用和良好降压效果,日益成为研究热点。
2.
Preparation of antihypertensive peptides from casein and its hypertensive effects were investigated in this paper.
本文研究乳酪蛋白源抗高血压活性肽(Antihypertensive peptides of casein)的制备及其在体内与体外对高血压的影响。
4) antihypertensive
[英]['ænti,hɑipə'tensiv] [美][,ænti,haɪpɚ'tɛnsɪv, ,antaɪ-]
抗高血压
1.
Purification of antihypertensive from bovine colostrums;
牛初乳中抗高血压因子的分离纯化工艺
2.
Study on NO-Donating Antihypertensive AgentsⅠ. Synthesis and Antihypertensive Activity of C-3 Nitrate or Furoxan Substituted Benzopyrans;
一氧化氮供体型抗高血压药物的研究Ⅰ.C-3位具有硝酸酯和呋咱氮氧化物取代结构的苯骈吡喃类化合物的合成及其降压活性
3.
Objective: This paper aimed at studying the effect of antihypertensive factor in bovine colostrums onintracellular calcium concentration ([Ca~(2+)]i) in adult rat ventricular myocytes induced by KCi, and investigatethe possible mechanism of AFBC to the cardiac muscle contraction s inhibitory action.
目的：本课题旨在研究牛初乳中抗高血压因子(AFBC)对氯化钾诱发的大鼠心肌细胞内钙离子浓度([Ca~(2+)]_i)变化的影响，研究其心肌收缩抑制作用的可能机制。
5) antihypertension
抗高血压
1.
Examining the effectiveness of hydragogue in antihypertension treatment from the perspective of evidence-based medicine;
从循证医学角度审视利尿剂在抗高血压治疗上的作用
2.
and their bioactivities of antineoplastic, antimicrobial, antihypertension and antioxidation were reviewed in this paper.
概述存在于海绵、海鞘等海洋低等生物和海洋鱼贝类中的生物活性肽,以及这些活性肽的抗肿瘤、 抗菌、抗高血压及抗氧化等生物活性的研究进展。
6) anti-hypertension
抗高血压
1.
Experimental study of effective part of Ampelopsis. megalophylla Diels et. Gilg on the anti-hypertension activity;
大叶蛇葡萄抗高血压有效部位筛选实验研究
2.
The merging hypertension\'s 132 example patients,taking coronary disease as being out of hospital diagnosis,were carried on appraisal of the anti-hypertension drug utilization,in some university affiliated hospital in January,2008~August,2008.
方法采用药物利用评价(DUR)方法,对某大学附属医院2008年1~8月期间,以冠心病为出院诊断,合并高血压的132例患者进行抗高血压药物利用评价。
补充资料：恶性高血压
恶性高血压
又称"急进型高血压病"。占高血压病的1％左右。其表现基本上与缓进型高血压病相似，但病情严重，病程发展迅速，舒张压常持续在17.3kPa(130mmHg）以上，伴有视网膜病变和肾功能迅速衰竭等特点。最后多因尿毒症而死亡，但也可死于脑血管意外和心力衰竭。治疗应选用降压作用强的药物，如可乐宁、长压定等；如出现肾功能衰竭，则降压药物以用甲基多巴、肼苯哒嗪、哌唑嗪等为妥。但不宜使血压下降得太显著，以免肾血流量减少而加重肾功能衰竭。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条